These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14163031)

  • 1. HEPARIN-LIKE SUBSTANCES AND ATHEROSCLEROSIS; A CLINICAL SURVEY AFTER FOUR YEARS OF THERAPEUTIC USE OF A DUODENAL HEPARINOID.
    COSTA U; AZZENA D; ASTENGO F; GHIGLIOTTI G
    G Gerontol; 1964 Feb; 12():201-2. PubMed ID: 14163031
    [No Abstract]   [Full Text] [Related]  

  • 2. [ACTION OF A DUODENAL HEPARINOID ON PLASMA LIPIDS AND SUGARS].
    BERRETA JA; CAMPAGNOLI M; SALITA S; LOFFLER AJ; ZUNDER J; PRESS L; BARBEITOARANDA A; KALINOV A
    Prensa Med Argent; 1964 Nov; 51():1267-71. PubMed ID: 14240198
    [No Abstract]   [Full Text] [Related]  

  • 3. [ACTION OF A SYNTHETIC HEPARINOID ON THE HUMORAL SYNDROME OF ATHEROSCLEROSIS].
    RAYNAUD R; BROCHIER ; TADEI
    Rev Atheroscler; 1963; 5():23-31. PubMed ID: 14121729
    [No Abstract]   [Full Text] [Related]  

  • 4. FIRST RESULTS ON THE TREATMENT OF DISLIPEMIAS OBTAINED WITH THE USE OF A PANCREATIC HEPARIN-LIKE SUBSTANCE.
    AZZENA D; GHIGLIOTTI G; ASTENGO F; MOLINELLI G
    G Gerontol; 1964 Feb; 12():169-70. PubMed ID: 14163027
    [No Abstract]   [Full Text] [Related]  

  • 5. [CLEARING ACTION OF HEPARIN AND HEPARINOID SUBSTANCES IN THERAPY OF ARTERIOSCLEROSIS].
    MEONI G
    Clin Ter; 1965 Mar; 32():445-60. PubMed ID: 14333171
    [No Abstract]   [Full Text] [Related]  

  • 6. [Survey of lipid metabolism in 100 patients suspected of atherosclerosis. Therapeutic trial of a new synthetic heparinoid: CB 8061. (Apropos of 30 cases)].
    LEBLOIS J; LESAGE R; RIVET E
    Lille Med; 1962 Mar; 7():256-63. PubMed ID: 14463327
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical aspects of the hypocholesterolemic and clearing action of a heparinoid and its relation to atherosclerosis].
    ALMAFARA ML; ORLANDO MM
    Sem Med; 1962 Mar; 120():433-6. PubMed ID: 13860649
    [No Abstract]   [Full Text] [Related]  

  • 8. [THE SIGNIFICANCE OF INSUFFICIENT CLEARANCE IN ATHEROGENESIS].
    SCHOEN H
    Munch Med Wochenschr; 1963 Dec; 105():2473-8. PubMed ID: 14133657
    [No Abstract]   [Full Text] [Related]  

  • 9. [On oral treatment with heparin and heparinoids].
    HEYMANN W
    Bibl Haematol; 1963; 15():132-9. PubMed ID: 13954327
    [No Abstract]   [Full Text] [Related]  

  • 10. The blood heparinoid substances in human atherosclerosis.
    NIKKILA EA; MAJANEN S
    Scand J Clin Lab Invest; 1952; 4(3):204-10. PubMed ID: 13014993
    [No Abstract]   [Full Text] [Related]  

  • 11. [Modifications in various classes of lipoproteins produced by the admininistration of a heparinoid extracted from the duodenal mucosa].
    AZZENA D; ASTENGO F GHIGLIOTTI G
    Minerva Med; 1959 Jul; 50():2190-2. PubMed ID: 13795424
    [No Abstract]   [Full Text] [Related]  

  • 12. [THERAPEUTIC TRIAL OF A SYNTHETIC HEPARINOID IN ARTERIAL DISEASES OF THE EXTREMITIES (CAUSED BY ATHEROSCLEROSIS)].
    PIERRON J
    Mars Med; 1963; 100():1267-74. PubMed ID: 14103616
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of a heparinoid extracted from duodenal mucosa on total cholesterolemia in atherosclerosis].
    GALLO E; SERRA GC
    Minerva Cardioangiol; 1960 Aug; 8():395-8. PubMed ID: 13703180
    [No Abstract]   [Full Text] [Related]  

  • 14. [HYALURONIDASE AND HEPARINOIDS IN THE TREATMENT OF SOME CUTANEOUS DISEASES].
    GHISLANZONI G
    G Ital Dermatol; 1964; 105():437-40. PubMed ID: 14209909
    [No Abstract]   [Full Text] [Related]  

  • 15. THE EFFECT OF TRIPARANOL AND OF HEPARINOID ON SPONTANEOUS ATHEROSCLEROSIS OF HENS.
    MALINOW MR; MARINI MA; LEMA B; NEBBIA M; BERARDI JA
    Acta Physiol Lat Am; 1964; 14():71-6. PubMed ID: 14175168
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of heparinoid on the proliferation of rabbit vascular smooth muscle cells in vitro].
    He W; Zhou X; Xu H; Zhou X
    Yao Xue Xue Bao; 1998; 33(1):5-9. PubMed ID: 11938935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and hematochemical observations on the geriatric and gerioprophylactic applications of a heparinoid agent associated with hormovitaminic factors and iodine].
    BENEDETTI G; MAZZA F; FERRETTI GF
    Minerva Med; 1961 Sep; 52():3347-51. PubMed ID: 13867125
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the effect of a heparinoid extracted from the duodenal mucosa on changes of serum lipoids after parenteral fat infusion].
    HAMMERL H; HENK W; HOLLER I; PICHLER O
    Wien Klin Wochenschr; 1963 Jan; 75():64-7. PubMed ID: 13952385
    [No Abstract]   [Full Text] [Related]  

  • 19. Heparin, non-heparin glycosaminoglycans, and heparinoids: an overview of their application in atherosclerosis.
    Engelberg H
    Semin Thromb Hemost; 1991; 17 Suppl 1():5-8. PubMed ID: 1712511
    [No Abstract]   [Full Text] [Related]  

  • 20. [ACTION OF DUODENAL HEPARINOID ON GLUCIDE METABOLISM].
    BARBEITOARANDA A; PRESS L; GIORDANO J; LOPEZGIL AL; CAMPAGNOLI M
    Dia Med; 1963 Sep; 35():1491-3. PubMed ID: 14089621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.